Aigen Investment Management, LP Grifols Sa Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$10.37 - $12.73 $244,939 - $300,682	-23,620 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.21 - $15.27 $241,160 - $360,677	23,620 New	23,620 $260,000
Q4 2020 Feb 12, 2021	SELL	$16.86 - $19.67 $1.56 Million - $1.82 Million	-92,734 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$15.4 - $20.16 $1.19 Million - $1.56 Million	77,299 Added 500.8%	92,734 $1.61 Million
Q2 2020 Aug 10, 2020	SELL	$18.24 - $21.45 $209,595 - $246,481	-11,491 Reduced 42.68%	15,435 $282,000
Q1 2020 May 08, 2020	SELL	$16.28 - $25.63 $190,459 - $299,845	-11,699 Reduced 30.29%	26,926 $542,000
Q4 2019 Feb 04, 2020	BUY	$19.57 - $23.52 $755,891 - $908,460	38,625 New	38,625 $900,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.